Ivica FUCEK

Person

Frankfurt, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Tandem diabody for CD16A-directed NK-cell engagement
- Patent number 12,264,198
- Issue date Apr 1, 2025
- AFFIMED GMBH
- Thorsten Ross
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific EGFR/CD16 antigen-binding protein
- Patent number 12,076,384
- Issue date Sep 3, 2024
- Affimed GMBH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent FV antibodies
- Patent number 11,572,415
- Issue date Feb 7, 2023
- Affimed GMBH
- Kristina Ellwanger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific EGFR/CD16 antigen-binding protein
- Patent number 11,510,972
- Issue date Nov 29, 2022
- Affimed GMBH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tandem diabody for CD16A-directed NK-cell engagement
- Patent number 11,180,558
- Issue date Nov 23, 2021
- Affimed GMBH
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NK cell engaging antibody fusion constructs
- Patent number 11,001,633
- Issue date May 11, 2021
- Affimed GMBH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 10,626,190
- Issue date Apr 21, 2020
- Amphivena Therapeutics, Inc.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody binding sites specific for EGFRvIII
- Patent number 10,273,309
- Issue date Apr 30, 2019
- AFFEMED GMBH
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD3 binding domains
- Patent number 10,066,015
- Issue date Sep 4, 2018
- Affirmed GmbH
- Eugene Zhukovsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,803,029
- Issue date Oct 31, 2017
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific CD33 and CD3 binding proteins
- Patent number 9,212,225
- Issue date Dec 15, 2015
- AMPHIVENA THERAPEUTICS, INC.
- Kristina Ellwanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS
- Publication number 20240294647
- Publication date Sep 5, 2024
- Affimed GmbH
- Michael Tesar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISPECIFIC BINDERS
- Publication number 20230365709
- Publication date Nov 16, 2023
- Affimed GmbH
- Thorsten ROSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN
- Publication number 20230190900
- Publication date Jun 22, 2023
- Affimed GmbH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20220041717
- Publication date Feb 10, 2022
- Affimed GmbH
- Thorsten ROSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS
- Publication number 20210253698
- Publication date Aug 19, 2021
- Affimed GmbH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20210024654
- Publication date Jan 28, 2021
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN
- Publication number 20200405833
- Publication date Dec 31, 2020
- Affimed GmbH
- Michael Kluge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS
- Publication number 20200109202
- Publication date Apr 9, 2020
- Affimed GmbH
- Michael Tesar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tandem Diabody for CD16A-directed NK-cell Engagement
- Publication number 20190345249
- Publication date Nov 14, 2019
- Thorsten Ross
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT FV ANTIBODIES
- Publication number 20190040155
- Publication date Feb 7, 2019
- Affimed GmbH
- Kristina ELLWANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20180291113
- Publication date Oct 11, 2018
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160194409
- Publication date Jul 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII
- Publication number 20160152728
- Publication date Jun 2, 2016
- Affimed GmbH
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3 BINDING DOMAINS
- Publication number 20160039934
- Publication date Feb 11, 2016
- Affimed GmbH
- Eugene ZHUKOVSKY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific CD33 and CD3 Binding Proteins
- Publication number 20160002333
- Publication date Jan 7, 2016
- Amphivena Therapeutics, Inc.
- Kristina ELLWANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ivica FUCEK

Person

Patents Grantslast 30 patents

Tandem diabody for CD16A-directed NK-cell engagement

Bispecific EGFR/CD16 antigen-binding protein

Multivalent FV antibodies

Bispecific EGFR/CD16 antigen-binding protein

Tandem diabody for CD16A-directed NK-cell engagement

NK cell engaging antibody fusion constructs

Bispecific CD33 and CD3 binding proteins

Antibody binding sites specific for EGFRvIII

CD3 binding domains

Bispecific CD33 and CD3 binding proteins

Bispecific CD33 and CD3 binding proteins

Patents Applicationslast 30 patents

USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS

TRISPECIFIC BINDERS

BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN

Tandem Diabody for CD16A-directed NK-cell Engagement

USES OF NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS FOR TREATMENTS

Bispecific CD33 and CD3 Binding Proteins

BISPECIFIC EGFR/CD16 ANTIGEN-BINDING PROTEIN

NK CELL ENGAGING ANTIBODY FUSION CONSTRUCTS

Tandem Diabody for CD16A-directed NK-cell Engagement

MULTIVALENT FV ANTIBODIES

Bispecific CD33 and CD3 Binding Proteins

Bispecific CD33 and CD3 Binding Proteins

ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII

CD3 BINDING DOMAINS

Bispecific CD33 and CD3 Binding Proteins